Whole Exome Sequencing (WES) is a cutting-edge genetic testing technique that has revolutionized the field of personalized medicine. By focusing on the exome – the part of the genome that codes for proteins – WES allows for the identification of genetic mutations that may be responsible for a wide range of diseases. This technology provides a powerful tool for diagnosing rare genetic disorders, guiding treatment decisions, and advancing our understanding of human genetics.

Whole Exome Sequencing is a genomic technique that sequences all the protein-coding regions of genes in a genome. These protein-coding regions, known as exons, make up about 1-2% of the human genome but are responsible for nearly 85% of known disease-related genetic variants. 

Key Features of WES:

• Targeted Sequencing: WES focuses on exons, which are the most functionally important parts of the genome.
• Comprehensive Analysis: By analyzing all exons, WES can detect mutations across thousands of genes simultaneously.
• Cost-Effective: WES is less expensive than whole genome sequencing while still providing valuable genetic information.
• Broad Application: WES can be used to diagnose a wide range of genetic disorders, from rare diseases to common complex conditions.

Whole Exome Sequencing (WES) represents a major advancement in genetic testing, offering a powerful and efficient way to explore the genetic underpinnings of disease. With its ability to diagnose rare disorders, guide personalized treatments, and contribute to medical research, WES is a vital tool in the era of precision medicine. 

“All treatments are provided by our contracted healthcare facilities, each of which holds the International Health Tourism Authorization Certificate.”